1. Home
  2. DH vs ATYR Comparison

DH vs ATYR Comparison

Compare DH & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Definitive Healthcare Corp.

DH

Definitive Healthcare Corp.

HOLD

Current Price

$0.96

Market Cap

107.6M

Sector

Technology

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.94

Market Cap

92.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DH
ATYR
Founded
2011
2005
Country
United States
United States
Employees
N/A
58
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.6M
92.8M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
DH
ATYR
Price
$0.96
$0.94
Analyst Decision
Hold
Hold
Analyst Count
5
9
Target Price
$3.08
$3.67
AVG Volume (30 Days)
243.0K
986.3K
Earning Date
05-07-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
63.28
N/A
EPS
N/A
N/A
Revenue
$241,521,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.89
$0.64
52 Week High
$4.70
$7.29

Technical Indicators

Market Signals
Indicator
DH
ATYR
Relative Strength Index (RSI) 42.22 59.04
Support Level $0.93 $0.68
Resistance Level $1.19 $1.12
Average True Range (ATR) 0.08 0.07
MACD 0.00 0.02
Stochastic Oscillator 25.01 63.30

Price Performance

Historical Comparison
DH
ATYR

About DH Definitive Healthcare Corp.

Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Share on Social Networks: